| scholarly article | Q13442814 |
| P50 | author | Jun Asai | Q40261322 |
| Kazuichi Maruyama | Q47149002 | ||
| Yusuke Mizukami | Q59678803 | ||
| P2093 | author name string | Masaaki Ii | |
| Corinne Luedemann | |||
| Douglas W Losordo | |||
| Marcy Silver | |||
| Young-sup Yoon | |||
| Tina Thorne | |||
| Andrea Wecker | |||
| Hideya Takenaka | |||
| Elizabeth Eaton | |||
| Kayoko Ibusuki | |||
| P433 | issue | 5 | |
| P921 | main subject | endothelium | Q111140 |
| P304 | page(s) | 697-704 | |
| P577 | publication date | 2006-02-16 | |
| P1433 | published in | Circulation Research | Q2599020 |
| P1476 | title | Endothelial progenitor thrombospondin-1 mediates diabetes-induced delay in reendothelialization following arterial injury | |
| P478 | volume | 98 |
| Q39147616 | A Preliminary Study of the Therapeutic Role of Human Early Fetal Aorta-derived Endothelial Progenitor Cells in Inhibiting Carotid Artery Neointimal Hyperplasia |
| Q38156645 | A reappraisal of the role of circulating (progenitor) cells in the pathobiology of diabetic complications. |
| Q35126265 | Activation of peroxisome proliferator-activated receptor-{delta} enhances regenerative capacity of human endothelial progenitor cells by stimulating biosynthesis of tetrahydrobiopterin |
| Q37413615 | Adenoviral transfer of HIF-1alpha enhances vascular responses to critical limb ischemia in diabetic mice |
| Q60104118 | Adult Stem Cells and Diabetes Therapy |
| Q38008390 | Advances in wound healing: a review of current wound healing products |
| Q37183949 | Aging and disease as modifiers of efficacy of cell therapy |
| Q48058641 | Aliskiren directly improves endothelial progenitor cell function from Type II diabetic patients |
| Q39112063 | Apurinic/apyrimidinic endonucelase 1 maintains adhesion of endothelial progenitor cells and reduces neointima formation |
| Q42365573 | Association between mobilization of circulating endothelial progenitor cells and time or degree of injury from angioplasty in patients with exertional angina: A prospective study |
| Q59792786 | Beneficial Effects of Deoxyshikonin on Delayed Wound Healing in Diabetic Mice |
| Q33312205 | Blockade of thrombospondin-1-CD47 interactions prevents necrosis of full thickness skin grafts |
| Q30514533 | Blood flow reprograms lymphatic vessels to blood vessels |
| Q84642747 | Bone Marrow-Derived Endothelial Progenitor Cells: Isolation and Characterization for Myocardial Repair |
| Q35608190 | Bone marrow-derived CMPs and GMPs represent highly functional proangiogenic cells: implications for ischemic cardiovascular disease |
| Q37328461 | Bone marrow-derived Kruppel-like factor 10 controls reendothelialization in response to arterial injury |
| Q37967719 | CD34-positive stem cells: in the treatment of heart and vascular disease in human beings |
| Q42696518 | Cardiac Adipose-Derived Stem Cells Exhibit High Differentiation Potential to Cardiovascular Cells in C57BL/6 Mice |
| Q37879584 | Cell-based therapies for diabetic retinopathy |
| Q36731424 | Cell-free embryonic stem cell extract-mediated derivation of multipotent stem cells from NIH3T3 fibroblasts for functional and anatomical ischemic tissue repair. |
| Q38044330 | Cell-specific insulin resistance: implications for atherosclerosis |
| Q37859918 | Cellular and molecular mechanisms of vascular injury in diabetes--part II: cellular mechanisms and therapeutic targets |
| Q34473701 | Characteristics of circulating CD31(+) cells from patients with coronary artery disease |
| Q84587243 | Combined growth factors enhanced angiogenic potential of cord blood-derived mononuclear cells transplanted to ischemic limbs |
| Q37534988 | Coronary vessel development and insight towards neovascular therapy. |
| Q36207052 | Correlation between the functional impairment of bone marrow-derived circulating progenitor cells and the extend of coronary artery disease. |
| Q33649275 | Diabetes and vessel wall remodelling: from mechanistic insights to regenerative therapies. |
| Q36301365 | Diabetic angiopathy and angiogenic defects |
| Q51069248 | Diesel exhaust particles impair endothelial progenitor cells, compromise endothelial integrity, reduce neoangiogenesis, and increase atherogenesis in mice. |
| Q35820068 | Differential healing after sirolimus, paclitaxel, and bare metal stent placement in combination with peroxisome proliferator-activator receptor gamma agonists: requirement for mTOR/Akt2 in PPARgamma activation |
| Q37131598 | Differentiation of bone marrow-derived endothelial progenitor cells is shifted into a proinflammatory phenotype by hyperglycemia |
| Q37568644 | Direct contact of umbilical cord blood endothelial progenitors with living cardiac tissue is a requirement for vascular tube-like structures formation. |
| Q49787990 | Endothelial Cell Metabolism. |
| Q35947546 | Endothelial dysfunction and diabetes: effects on angiogenesis, vascular remodeling, and wound healing |
| Q36933858 | Endothelial progenitor cells for the treatment of diabetic vasculopathy: panacea or Pandora's box? |
| Q37066764 | Endothelial progenitor cells in neovascularization of infarcted myocardium |
| Q28303395 | Endothelial progenitor cells: identity defined? |
| Q21198698 | Endothelial progenitor cells: what use for the cardiologist? |
| Q46921463 | Endothelium-targeted transgenic GTP-cyclohydrolase I overexpression inhibits neointima formation in mouse carotid artery |
| Q26859263 | Epigenetic Changes in Endothelial Progenitors as a Possible Cellular Basis for Glycemic Memory in Diabetic Vascular Complications |
| Q36796396 | Experimental model for coadjuvant treatment with mesenchymal stem cells for aortic aneurysm |
| Q42588858 | Feeding sugar to tumors: with a supplement of miR? |
| Q34413885 | GTP cyclohydrolase I/BH4 pathway protects EPCs via suppressing oxidative stress and thrombospondin-1 in salt-sensitive hypertension |
| Q30397422 | Genetic and epigenetic events in diabetic wound healing |
| Q33820841 | Genous endothelial progenitor cell capturing stent vs. the Taxus Liberte stent in patients with de novo coronary lesions with a high-risk of coronary restenosis: a randomized, single-centre, pilot study |
| Q37538723 | Genous endothelial progenitor cell-capturing stent system: a novel stent technology |
| Q34355975 | Growth factors/chemokines in diabetic vitreous and aqueous alter the function of bone marrow-derived progenitor (CD34⁺) cells in humans |
| Q46488605 | High glucose reduces cathepsin L activity and impairs invasion of circulating progenitor cells |
| Q36815075 | Human Bone Marrow Subpopulations Sustain Human Islet Function and Viability In vitro |
| Q37216686 | Hyperoxia, endothelial progenitor cell mobilization, and diabetic wound healing |
| Q37494247 | Impaired function of circulating CD34(+) CD45(-) cells in patients with proliferative diabetic retinopathy |
| Q34718887 | Insulin resistance impairs circulating angiogenic progenitor cell function and delays endothelial regeneration |
| Q51744143 | Interaction of platelets with endothelial progenitor cells in the experimental atherosclerosis: Role of transplanted endothelial progenitor cells and platelet microparticles. |
| Q38311517 | MicroRNA miR-27b rescues bone marrow-derived angiogenic cell function and accelerates wound healing in type 2 diabetes mellitus. |
| Q92819892 | MicroRNA-126 protects against vascular injury by promoting homing and maintaining stemness of late outgrowth endothelial progenitor cells |
| Q38183938 | Next-generation DES: the COMBO dual therapy stent with Genous endothelial progenitor capturing technology and an abluminal sirolimus matrix |
| Q34222260 | Nitric oxide synthase expression and functional response to nitric oxide are both important modulators of circulating angiogenic cell response to angiogenic stimuli |
| Q39626523 | Notch signaling regulates endothelial progenitor cell activity during recovery from arterial injury in hypercholesterolemic mice |
| Q37133201 | Oxidative stress-mediated thrombospondin-2 upregulation impairs bone marrow-derived angiogenic cell function in diabetes mellitus |
| Q35185979 | Poor functional recovery after transplantation of diabetic bone marrow stem cells in ischemic myocardium |
| Q37557559 | Priming of mononuclear cells with a combination of growth factors enhances wound healing via high angiogenic and engraftment capabilities |
| Q37053167 | Progenitor cells and vascular disease |
| Q38078140 | Restoring stem cell mobilization to promote vascular repair in diabetes. |
| Q37976449 | Revisiting cardiovascular regeneration with bone marrow-derived angiogenic and vasculogenic cells |
| Q37121476 | Stem cell research: a novel boulevard towards improved bovine mastitis management |
| Q38209423 | Stem cell therapies in the management of diabetic retinopathy |
| Q38603660 | Stem cell therapies in the treatment of diabetic retinopathy and keratopathy |
| Q34201082 | Systemic influences contribute to prolonged microvascular rarefaction after brain irradiation: a role for endothelial progenitor cells |
| Q55346713 | The Vasoreparative Function of Myeloid Angiogenic Cells Is Impaired in Diabetes Through the Induction of IL1β. |
| Q33562214 | The dual PPARα/γ agonist aleglitazar increases the number and function of endothelial progenitor cells: implications for vascular function and atherogenesis |
| Q36892494 | The impact of insulin resistance on endothelial function, progenitor cells and repair |
| Q42881647 | The renin inhibitor aliskiren upregulates pro-angiogenic cells and reduces atherogenesis in mice |
| Q41933144 | The role of thrombospondin (TSP)-1 in obesity and diabetes |
| Q24633525 | Thrombospondin-1 signaling through CD47 inhibits self-renewal by regulating c-Myc and other stem cell transcription factors |
| Q37439793 | Thrombospondin-1/CD36 pathway contributes to bone marrow-derived angiogenic cell dysfunction in type 1 diabetes via Sonic hedgehog pathway suppression |
| Q36682256 | Tissue kallikrein is essential for invasive capacity of circulating proangiogenic cells. |
| Q53415035 | Trace Amounts of Copper in Drinking Water Aggravate Cerebral Ischemic Injury via Impairing Endothelial Progenitor Cells in Mice. |
| Q30499092 | Transplanting normal vascular proangiogenic cells to tumor-bearing mice triggers vascular remodeling and reduces hypoxia in tumors |
| Q37115995 | Vascular progenitor cells and diabetes: role in postischemic neovascularisation. |
| Q38150963 | Whole brain radiation-induced vascular cognitive impairment: mechanisms and implications |
Search more.